Maximus FY2025 revenue $5.43B (+2.4%), adj. EPS $7.36; FY2026 guidance adj. EPS $7.95-$8.25, rev $5.225B-$5.425B

MAXIMUS, INC.

2025-FY EPS reported $5.51 revenue$5,431,276,000

Full year revenue $5.43B (+2.4% YoY); organic growth 3.9% driven by U.S. Federal clinical programs.
Full year adjusted diluted EPS $7.36 (vs $6.11 prior); operating margin expanded to 9.7% (prior 9.2%).
Free cash flow $366M; share repurchases of 5.8M shares for $457M; leverage ratio 1.5x at Sep 30, 2025.
FY2026 guidance: revenue $5.225B-$5.425B, adjusted EBITDA margin ~13.7%, adjusted EPS $7.95-$8.25, FCF $450M-$500M.
U.S. Federal Services revenue +12.1% to $3.07B, margin 15.3%; U.S. Services -7.7% to $1.76B on Medicaid unwinding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.